Literature DB >> 16084767

Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs.

Martin Brunner1, Hartmut Derendorf, Markus Müller.   

Abstract

Inadequate tissue penetration of antibiotics can lead to therapeutic failure and bacterial resistance. Pharmacokinetic evaluation of antibiotics should therefore be based on tissue rather than serum concentrations. Over several years, tissue concentration data obtained by methods such as tissue biopsies have flawed the correct interpretation of antibiotic tissue distribution. Microdialysis--a semi-invasive catheter-based sampling technique--has been employed for the in vivo measurement of antibiotic tissue pharmacokinetics. Owing to selective access to the target site for most anti-infective drugs, microdialysis satisfies regulatory requirements for pharmacokinetic distribution studies and might become a reference technique for tissue distribution studies in the near future. Furthermore, microdialysis might contribute to the definition of meaningful surrogate markers for antibiotic efficiency during drug development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084767     DOI: 10.1016/j.coph.2005.04.010

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  19 in total

1.  Comment on "Levels of vancomycin in the cerebral interstitial fluid after severe head injury" by Caricato et al.

Authors:  Sandra Magnoni; Elisa Roncati Zanier; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

2.  Application of basic pharmacokinetic concepts to analysis of microdialysis data: illustration with imipenem muscle distribution.

Authors:  Claire Dahyot; Sandrine Marchand; Mikael Bodin; Bertrand Debeane; Olivier Mimoz; William Couet
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 3.  Integrated pharmacokinetics and pharmacodynamics in drug development.

Authors:  Jasper Dingemanse; Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 4.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 5.  A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.

Authors:  Tony K L Kiang; Urs O Häfeli; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

Review 6.  Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.

Authors:  Amelia N Deitchman; M Tobias Heinrichs; Vipada Khaowroongrueng; Satyawan B Jadhav; Hartmut Derendorf
Journal:  AAPS J       Date:  2016-12-09       Impact factor: 4.009

7.  Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.

Authors:  Estevan Sonego Zimmermann; João Victor Laureano; Camila Neris Dos Santos; Stephan Schmidt; Chakradhar V Lagishetty; Whocely Victor de Castro; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

8.  Is the penetration of clindamycin into the masseter muscle really enough to treat odontogenic infections?

Authors:  Paula I Faggion; Gabriela Isoton; Eduarda Possa; Leandro Tasso
Journal:  Clin Oral Investig       Date:  2020-10-31       Impact factor: 3.573

Review 9.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

Review 10.  Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.

Authors:  Ashit Trivedi; Richard E Lee; Bernd Meibohm
Journal:  Expert Rev Clin Pharmacol       Date:  2013-03       Impact factor: 5.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.